E20.8
Other hypoparathyroidism
Clinical Classification Guidelines
Medical Intelligence & Overview
Other hypoparathyroidism (ICD-10 Code E20.8) is a condition characterized by insufficient production or activity of parathyroid hormone (PTH) from the parathyroid glands. These small glands, located in the neck near the thyroid, play a crucial role in regulating calcium and phosphorus levels in the blood. When PTH levels are abnormally low, it leads to disturbances in calcium balance, which can affect various bodily functions. This condition is a specific classification that encompasses forms of hypoparathyroidism not categorized elsewhere, making it important to understand its causes, symptoms, diagnosis, and management.
Causes & Symptoms
Clinical Causes: Idiopathic hypoparathyroidism, where the cause is unknown Genetic disorders affecting parathyroid development or function Autoimmune destruction of the parathyroid glands Surgical removal or damage during neck surgeries, such as thyroidectomy Radiation therapy to the neck area Magnesium deficiency, which can impair PTH secretion and action Hypoparathyroidism associated with other endocrine disorders or syndromes
Key Symptoms: Muscle cramps, spasms, or twitching (tetany) Numbness or tingling sensation, especially around the mouth and in extremities Fatigue and weakness Cognitive disturbances, including anxiety or depression Difficulty breathing during severe episodes due to laryngospasm Dry skin, brittle nails, or hair loss Seizures in severe cases Dental abnormalities, such as delayed eruption or poor tooth development
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other hypoparathyroidism involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - Blood tests showing low calcium levels and elevated phosphorus levels - Reduced or undetectable levels of parathyroid hormone (PTH) - Electrolyte panels to evaluate other related imbalances - Confirmatory tests to exclude other causes of hypocalcemia - Medical imaging, such as ultrasound or sestamibi scans, may be used to assess the parathyroid glands if structural abnormalities are suspected - Genetic testing in cases with suspected hereditary causes
Treatment Protocols: Treatment strategies focus on restoring and maintaining normal calcium and phosphorus levels. Common approaches include: - Oral calcium supplements to correct hypocalcemia - Active forms of vitamin D (e.g., calcitriol) to enhance calcium absorption - Magnesium supplementation if deficiency is identified - Dietary modifications to increase calcium intake - Monitoring of serum calcium and phosphorus levels regularly to adjust therapy - In some cases, recombinant PTH may be considered under specialist guidance - Managing symptoms with anticonvulsants or muscle relaxants if necessary - Addressing underlying causes, such as autoimmune or surgical factors, to prevent further damage
Clinical Advice & FAQs
Billing Guidance
Is E20.8 a billable ICD-10 code?
Yes, E20.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E20.8?
Clinical documentation must specify the nature of Other hypoparathyroidism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference